Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLogistics Dev Regulatory News (LDG)

Share Price Information for Logistics Dev (LDG)

Share Price is delayed by 15 minutes
Get Live Data
13.75    0.00 (0.00%)
Bid:
13.50
Ask:
14.00
Spread: 0.50 (3.704%)
Market Cap: £56.90m
LDG Live PriceLast checked at - London Stock Exchange

Intraday Logistics Dev Share Chart

Alliance Pharma Investment - Update

10 Jan 2025 07:29

RNS Number : 8959S
Logistics Development Group PLC
10 January 2025
 

10 January 2025

 

Logistics Development Group plc

("LDG", the "Company" or, with its subsidiaries, the "Group")

Alliance Pharma Investment - Update

 

LDG is pleased to note that the boards of Aegros Bidco Limited ("Bidco") and Alliance Pharma plc ("Alliance") have reached an agreement on the terms of a recommended acquisition at 62.5p per ordinary share of 1p each in the capital of Alliance ("Alliance Shares") in cash, valuing Alliance's issued share capital at £337.9 million, to be made by Bidco for the entire issued share capital of Alliance, other than the Alliance Shares held by funds advised or managed by DBAY Advisors Limited ("DBAY"), the Company's investment manager, including the Alliance Shares in which LDG is interested as noted below (the "Acquisition"). The Acquisition is intended to be implemented by means of a Court-sanctioned scheme of arrangement.

Alliance is a global healthcare platform that markets and distributes leading OTC consumer healthcare and prescription products. The business has over 290 employees and is headquartered in Chippenham, Wiltshire. For the year ended 31 December 2023, Alliance reported Adjusted EBITDA of £45.0 million on revenues of £180.7 million. As at 30 June 2024, Alliance had net assets of £222.9 million.

LDG is interested in 71,165,281 Alliance Shares, representing approximately 13.2% of Alliance's issued share capital, through Fixtaia Limited ("Fixtaia"). Pursuant to LDG's discretionary investment management agreement with DBAY, LDG's Alliance Shares are deemed to be part of the Alliance Shares held by funds advised or managed by DBAY, and consequently LDG is deemed to be acting in concert with DBAY for the purposes of the Acquisition.

Under the terms of the Acquisition, if completed, LDG through Fixtaia will be issued unlisted, non-voting B ordinary shares in Aegros Dominium Limited ("Equityco") (a holding company of Bidco) in consideration for each Alliance Share held (the "Equityco B Shares"). Accordingly, LDG is expected to receive, through Fixtaia, 71,165,281 Equityco B Shares in exchange for its Alliance shareholding.

Bidco was formed for the purposes of the Acquisition and is an entity controlled by funds advised or managed by DBAY.

LDG has no cash funding obligation or contribution in connection with the Acquisition, and it remains the Board's intention to proceed with a further distribution to shareholders through a tender offer, subject to, inter alia, shareholder approval. Consequently, the Offer will not affect LDG's current cash position.

A link to the full announcement (the "2.7 Announcement") in respect of the Acquisition will be made available at: https://www.dbayadvisors.com/. Capitalised terms used but not defined in this announcement shall have the same meaning as set out in the 2.7 Announcement.

For enquiries:

Logistics Development Group plc

Via FTI Consulting

FTI Consulting

Nick Hasell

Alex Le May

 

+44 (0) 20 3727 1340

Strand Hanson Limited

(Financial and Nominated Adviser)

James Spinney

Richard Johnson

Abigail Wennington

+44 (0) 20 7409 3494

 

Investec Bank plc

(Broker)

Gary Clarence

Harry Hargreaves

+44 (0) 20 7597 5970

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSFASWSEISEEF
Date   Source Headline
29th May 20267:00 amRNSPortfolio NAV Update
20th May 20267:00 amRNSPosting of Annual Report and Notice of AGM
15th May 20262:20 pmRNSPortfolio company update - acquisition
15th May 20267:00 amRNSFinal Results for the year ended 31 December 2025
17th Mar 202611:00 amRNSPortfolio company update - acquisition
27th Feb 20267:00 amRNSPortfolio NAV Update
22nd Jan 20267:00 amRNSPortfolio Update - Related Party Transaction
28th Nov 20257:00 amRNSPortfolio NAV Update
6th Nov 20257:00 amRNSAppointment of Corporate Broker
25th Sep 20257:00 amRNSInterim Results for six months ended 30 June 2025
5th Sep 20253:53 pmRNSHolding(s) in Company
29th Aug 20257:00 amRNSPortfolio NAV Update
18th Jul 20254:09 pmRNSInvestment into platform to acquire APC
25th Jun 202512:55 pmRNSResult of AGM
5th Jun 20257:00 amRNSUpdate re Directors’ & Concert Party shareholdings
30th May 20257:00 amRNSPortfolio NAV Update
28th May 20257:00 amRNSPosting of Annual Report and Notice of AGM
22nd May 20257:00 amRNSFinal Results for the 13 Months to 31 Dec 2024
24th Apr 20257:00 amRNSResults of Tender Offer
22nd Apr 202512:28 pmRNSResults of General Meeting
28th Mar 20257:00 amRNSProposed Tender Offer, Circular, & GM Notice
17th Mar 20257:00 amRNSPortfolio NAV and Distribution Update
10th Jan 202511:59 amRNSForm 8 (OPD) - Alliance Pharma PLC
10th Jan 20257:29 amRNSAlliance Pharma Investment - Update
10th Jan 20257:00 amRNSRecommended Acquisition of Alliance Pharma plc
24th Dec 202410:57 amRNSRedemption of investment; distribution update
29th Nov 20241:00 pmRNSBoard Changes, Change of Accounting Reference Date
16th Oct 20241:41 pmRNSResult of Requisitioned General Meeting
23rd Sep 20247:00 amRNSCircular Publication, Notice of Requisitioned GM
4th Sep 20243:29 pmRNSResults of General Meeting
4th Sep 20247:00 amRNSGeneral Meeting Requisition Notice
23rd Aug 20247:00 amRNSInterim Results for six months ended 31 May 2024
13th Aug 20247:00 amRNSCircular, Rule 9 Waiver & Notice of GM
5th Aug 202411:56 amRNSHolding(s) in Company
11th Jul 202411:02 amRNSHolding(s) in Company
11th Jul 20249:27 amRNSForm 8.3 - Mission Group PLC
12th Jun 20245:57 pmRNSNotification of Major Holdings
31st May 202411:00 amRNSForm 8.3 - Mission Group plc
30th May 20241:14 pmRNSForm 8.3 - Mission Group plc
30th May 202412:00 pmRNSNotification of Major Holdings
29th May 202410:16 amRNSForm 8.3 - Mission Group PLC
28th May 20241:09 pmRNSHolding(s) in Company
28th May 202410:52 amRNSForm 8.3 - Mission Group Plc
28th May 202410:34 amRNSForm 8.3
24th May 20242:44 pmRNSHolding(s) in Company
24th May 20248:56 amRNSHolding(s) in Company
23rd May 202411:21 amRNSForm 8.3 - Mission Group PLC
23rd May 20249:00 amRNSHolding(s) in Company
22nd May 202410:36 amRNSForm 8.3
21st May 202411:33 amRNSForm 8.3 - Mission Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.